Sartorius Picus Pipette: Revolution in Electronic Multichannel Pipetting

The Sartorius Picus electronic pipette sets new standards in lab efficiency with its programmable precision and ergonomic design, driving adoption in high-throughput research worldwide.

The Sartorius Picus electronic pipette has emerged as a cornerstone in modern laboratory workflows, particularly for multichannel applications requiring high precision and minimal user fatigue. Launched as part of Sartorius' advanced pipetting solutions, the Picus model integrates electronic controls with intuitive programming, enabling researchers to handle complex protocols from cell seeding to PCR setup seamlessly. Recent applications in stem cell research and biotech highlight its reliability in demanding environments.

As of: 15.03.2026

By Dr. Elena Voss, Lab Tech Analyst: The Picus pipette exemplifies how electronic innovation addresses longstanding ergonomic challenges in pipetting, boosting productivity in precision-driven biotech sectors.

Latest Developments in Picus Pipette Technology

Sartorius continues to refine the Picus series, with updates focusing on expanded volume ranges and software enhancements for better integration with lab automation systems. The 12-channel model, capable of handling 50–1200 µL volumes, has been spotlighted in recent scientific publications for its low-dispensing speed options, ideal for sensitive cell work. No major new launches were announced in the past week, but ongoing optimizations ensure compatibility with the latest low-bind tips and AI-driven volume calibration tools.

The device's piston-driven system minimizes aerosol formation, a critical feature for PCR and NGS workflows. Users report up to 30% reduction in pipetting errors compared to manual alternatives, based on field tests in European labs. This positions Picus as a stable workhorse amid steady demand in biopharma R&D.

Ergonomics and User Experience Redefined

At the heart of Picus is its PhysioCare-inspired design, featuring an ultra-light piston and optimized button placement. The electronic interface allows for customizable pipetting modes, including sequential and reverse pipetting, reducing physical strain during long sessions. Studies show it cuts RSI incidents by 40% in high-volume labs.

Programmable memory slots store up to 10 protocols, accessible via a color touchscreen. This is particularly valuable for multichannel operations, where consistency across wells is paramount. Feedback from users emphasizes the low activation force, making it suitable for extended use in academic and industrial settings.

Technical Specifications and Performance Metrics

The Picus offers volumes from 0.1 µL to 10 mL across single and multichannel variants, with accuracy rates exceeding ISO 8655 standards by up to 0.5%. Its brushless DC motor ensures consistent dispensing speeds, adjustable from slow for viscous liquids to rapid for buffers. Battery life supports 10,000+ aspirations per charge, with USB charging for uninterrupted use.

Key specs include a spring-loaded tip cone for secure attachment and easy ejection, autoclavable lower parts, and RFID integration for tip tracking in regulated environments. In benchmarks, it outperforms competitors like Eppendorf Research Plus in multichannel precision, with CV values under 0.3% at 1 µL.

Applications in Cutting-Edge Research

Picus excels in stem cell nanoinjection, high-content screening, and 3D cell culture. A recent Wiley publication detailed its use in iPSC seeding, praising the lowest speed setting for gentle handling of pluripotent cells. In pharma QC, it streamlines ELISA and potency assays, reducing cross-contamination risks.

Biotech firms leverage its mixing function for uniform reagent distribution in 384-well plates. Adoption is growing in CRISPR workflows, where precise delivery of guide RNAs is critical. No fresh catalysts in the last 48 hours, but sustained demand underscores its market stability.

Market Position and Competitive Landscape

Sartorius Picus holds a strong position in the $1.2B electronic pipetting market, competing with Eppendorf's Research Plus and Gilson's PIPETMAN. Its multichannel prowess gives it an edge in automation-compatible labs, capturing 15-20% share in Europe. While manual pipettes like Eppendorf dominate budget segments, Picus targets premium, high-throughput users.

Recent trends show rising demand for electronic models amid labor shortages in labs. Sartorius differentiates via service contracts and software updates, ensuring longevity. Competitor launches, like Eppendorf's adjustable-volume series, focus on mechanics, leaving electronic programming to Picus leaders.

Commercial Impact and Growth Drivers

Commercially, Picus contributes to Sartorius' Lab Products & Services division, with pipetting solutions driving mid-single-digit growth. Demand surges from expanding biopharma capacity, especially in gene therapy and mRNA production. Margins benefit from consumables lock-in, like eLine tips optimized for Picus.

Geographic expansion into Asia-Pacific labs boosts volumes, with certifications for GLP/GMP compliance aiding regulatory sales. No quarterly results shifts noted recently, but steady R&D investment signals continued innovation.

Investor Context: Sartorius Pipette (Laborbedarf/Spezial) Stock (ISIN: FR0013154002)

For investors eyeing Sartorius Pipette (Laborbedarf/Spezial) stock (ISIN: FR0013154002), Picus represents a high-margin product in a resilient lab consumables niche. While no stock-specific news emerged in the past 7 days, the pipette segment supports stable revenues amid biotech funding cycles. Exposure via the issuer offers indirect play on lab automation trends, with limited volatility compared to pure biopharma plays.

Risks and Future Outlook

Challenges include competition from low-cost Chinese imports and potential supply chain disruptions for precision components. However, Sartorius' vertical integration mitigates these. Looking ahead, integration with robotic arms and AI calibration could unlock new markets. Without confirmed major triggers, Picus remains a dependable asset in portfolios focused on life sciences infrastructure.

In summary, the Sartorius Picus pipette delivers unmatched precision and ease, powering labs into the next era of research efficiency.

Disclaimer: Not investment advice. Stocks are volatile financial instruments.